Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Treace Medical Concepts (TMCI) Debt to Equity (2020 - 2025)

Treace Medical Concepts' Debt to Equity history spans 6 years, with the latest figure at $0.66 for Q4 2025.

  • For Q4 2025, Debt to Equity rose 39.02% year-over-year to $0.66; the TTM value through Dec 2025 reached $0.66, up 39.02%, while the annual FY2025 figure was $0.66, 39.02% up from the prior year.
  • Debt to Equity reached $0.66 in Q4 2025 per TMCI's latest filing, up from $0.62 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.87 in Q4 2022 to a low of -$42.74 in Q1 2021.
  • Average Debt to Equity over 5 years is -$1.67, with a median of $0.45 recorded in 2024.
  • Peak YoY movement for Debt to Equity: plummeted 99.21% in 2021, then skyrocketed 181.03% in 2022.
  • A 5-year view of Debt to Equity shows it stood at $0.32 in 2021, then skyrocketed by 176.01% to $0.87 in 2022, then crashed by 55.87% to $0.38 in 2023, then grew by 22.87% to $0.47 in 2024, then skyrocketed by 39.02% to $0.66 in 2025.
  • Per Business Quant, the three most recent readings for TMCI's Debt to Equity are $0.66 (Q4 2025), $0.62 (Q3 2025), and $0.56 (Q2 2025).